J&J wins FDA OK for skin-patch drug (The Star-Ledger)
Johnson & Johnson has won regulatory clearance to begin selling a skin patch that allows post-surgery patients to give themselves a painkiller without a needle stick.

Amarillo Biosciences Announces Phase II Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in (SYS-CON Media)
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR)today announced submission to the FDA of a protocol for a Phase II study totest low-dose interferon alpha lozenges administered orally to humanimmunodeficiency virus (HIV)-positive subjects with oral warts. Virallesions of the mouth in patients infected with HIV are common and may beindicative of disease progression. One of the causes of oral lesions

FDA Clearance Under A Special Protocol Assessment To Initiate CoFactor Phase III Clinical Trial (Medical News Today)
ADVENTRX Pharmaceuticals,Inc. (Amex: ANX) announced today that it reached an agreement under aspecial protocol assessment (SPA) with the US Food and Drug Administration(FDA) on the design of the Company's CoFactor(R) Phase III clinical trialprotocol. The Company also announced it remains on track to initiate thePhase III clinical trial in Q2 2006. [click link for full article]